IL-17 targeting affibodies (Affibody)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIL-17 targeting affibodies (Affibody)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-17 inhibitors
TargetsInterleukin-17
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffibody Medical AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffibody Medical AB
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A